Response to: Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies.
作者信息
Kagan Risa, Cano Antonio, Nappi Rossella E, English Marci L, Mancuso Shayna, Wu Xi, Ottery Faith D
机构信息
University of California, San Francisco, CA, USA.
Sutter East Bay Medical Foundation, Berkeley, CA, USA.
出版信息
Adv Ther. 2025 Jun 4. doi: 10.1007/s12325-025-03243-2.
PMID:40465199
Abstract
摘要
Zotero 插件